Home » Topics » BioWorld Science

BioWorld Science
RSS

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

Oct. 26, 2021

Janssen BioPharma presents compounds for inhibiting respiratory syncytial virus replication

Oct. 26, 2021

Repurposing bumetanide for the treatment of APOE4-related AD

Oct. 26, 2021

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

The gut microbiota affects CRPC growth by contributing to androgen metabolism

Oct. 26, 2021

Therapeutic profiling unveils three functional subtypes of cancer-associated fibroblasts in NSCLC

Oct. 26, 2021

Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

Oct. 26, 2021

Gene-protein-disease map reveals connections within and between diseases

Oct. 25, 2021

ABHD16A deficiency linked to subtype of complicated hereditary spastic paraplegia

Oct. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...